In Vitro Selection of Modified RNA Aptamers Against CD44 Cancer Stem Cell Marker-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

In Vitro Selection of Modified RNA Aptamers Against CD44 Cancer Stem Cell Marker

Published:2013-12-01 Issue:6 Volume:23 Page:401-407
ISSN:2159-3337
Container-title:Nucleic Acid Therapeutics
language:en
Short-container-title:Nucleic Acid Therapeutics

Author:

Ababneh Nidaa¹,Alshaer Walhan²³,Al-Louzi Omar⁴,Mahafzah Azmi⁵,El-Khateeb Mohammed⁵,Hillaireau Hervé³,Noiray Magali³,Fattal Elias³,Ismail Said²

Affiliation:

1. Cell Therapy Center, University of Jordan, Amman, Jordan.

2. Molecular Biology Research Laboratory, University of Jordan, Amman, Jordan.

3. Université Paris-Sud, Faculté de Pharmacie, Châtenay-Malabry, France.

4. Faculty of Medicine, University of Jordan, Amman, Jordan.

5. Department of Immunology, Microbiology, and Forensic Medicine, University of Jordan, Amman, Jordan.

Publisher

Mary Ann Liebert Inc

Subject

Drug Discovery,Genetics,Molecular Biology,Molecular Medicine,Biochemistry

Link

https://www.liebertpub.com/doi/pdf/10.1089/nat.2013.0423

Reference25 articles.

1. Role of CD44s and CD44v6 on human breast cancer cell adhesion, migration, and invasion

2. CD44: A Cancer Stem Cell–Related Biomarker with Predictive Potential for Radiotherapy: Fig. 1.

3. Antibodies targeting cancer stem cells: A new paradigm in immunotherapy?

4. Cancer Stem Cells: The Seeds of Metastasis?

5. Significance of CD44 and CD24 as Cancer Stem Cell Markers: An Enduring Ambiguity

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aptamer-based Membrane Protein Analysis and Molecular Diagnostics;Chemical Research in Chinese Universities;2024-03-12

2. Aptamers as Potential Therapeutic Tools for Ovarian Cancer: Advancements and Challenges;Cancers;2023-11-06

3. Surface modification strategies in translocating nano-vesicles across different barriers and the role of bio-vesicles in improving anticancer therapy;Journal of Controlled Release;2023-11

4. Selection of DNA aptamer recognizing CD44 for high-eﬃciency capture of circulating tumor cells;Talanta;2023-09

5. Aptamers Targeting Membrane Proteins for Sensor and Diagnostic Applications;Molecules;2023-04-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3